Skip to Main Content

Author Details

Brian D Robinson
Sandra and Edward Meyer Cancer Center
2008
173
46
PMIDPaper TitleJournal TitlePublished Year
37406458HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.Int J Gynecol Pathol2024
36733939Clinical and molecular significance of the RNA m<sup>6</sup>A methyltransferase complex in prostate cancer.Front Genet2023
37528578Erythropoietin-secreting metanephric adenoma presenting as erythrocytosis.Am J Hematol2023
37581614SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.Clin Cancer Res2023
37546702The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.Cancer Res Commun2023
37579853Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy.Urology2023
37502956NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer.bioRxiv2023
37152294The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer.Front Cell Dev Biol2023
37034687Distinct mesenchymal cell states mediate prostate cancer progression.bioRxiv2023
34628719Comparative pathology of dog and human prostate cancer.Vet Med Sci2022
35490048A multidisciplinary approach to optimize primary prostate cancer biobanking.Urol Oncol2022
36518545Placental pathology, neonatal birth weight, and Apgar score in acute and distant SARS-CoV-2 infection.J Clin Transl Res2022
36263323Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.Front Endocrinol (Lausanne)2022
36291932The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.Cancers (Basel)2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
34932854FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.Mol Oncol2022
32948433Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.Urol Oncol2021
33719168A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.J Magn Reson Imaging2021
33563537Tumor size and genomic risk in localized prostate cancer.Urol Oncol2021
33929788Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.Cancer Cytopathol2021
34496233Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.Cell Rep2021
34522463Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations.Am J Cancer Res2021
34716216Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.J Am Soc Nephrol2021
34796255A case report of a patient with plasmacytoid urothelial cancer with significant response to HER2-targeting therapy and enfortumab vedotin.Am J Clin Exp Urol2021
34795264G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.Nat Commun2021
33941830Computer extracted gland features from H&amp;E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.NPJ Precis Oncol2021
33941504Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.Eur Urol Focus2021
34099734Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.Nat Commun2021
33118597Nested Variant of Urothelial Carcinoma Is a Luminal Bladder Tumor With Distinct Coexpression of the Basal Marker Cytokeratin 5/6.Am J Clin Pathol2021
33190043Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.Transl Oncol2021
32958411High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance.J Am Soc Cytopathol2021
32589068The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.Arch Pathol Lab Med2021
31492650Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.Eur Urol Oncol2020
31876580Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.Am J Surg Pathol2020
31789578Reply by Authors.J Urol2020
31727682Copolymerization of single-cell nucleic acids into balls of acrylamide gel.Genome Res2020
33273457Common germline-somatic variant interactions in advanced urothelial cancer.Nat Commun2020
32915138A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors.Elife2020
32979705Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experience.Cancer Treat Res Commun2020
32244564Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for Metastasis.Cancers (Basel)2020
32139401Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients.Clin Cancer Res2020
31502942Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study.J Urol2020
31378664Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267].Eur Urol Oncol2020
30470630Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?Clin Genitourin Cancer2019
31260412N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.J Clin Invest2019
31278255Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.Nat Commun2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
31249846Diagnosis and Genotyping of <i>Coxiella burnetii</i> Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA.Open Forum Infect Dis2019
31017088The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.Eur Urol Oncol2019
30865916Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.J Natl Compr Canc Netw2019
  • 1 - 50 of 173

Recommended Authors

Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of Toronto
Career Start Year 2013
Number of shared co-authors 4
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 7
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 1
University of Toronto
Career Start Year 2006
Number of shared co-authors 4
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 5
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 47
University of California San Diego
Career Start Year 2005
Number of shared co-authors 2
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 25
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 15
University of British Columbia
Career Start Year 2004
Number of shared co-authors 17
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 12
Northwestern University
Career Start Year 2003
Number of shared co-authors 43
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 15
University College London
Career Start Year 1999
Number of shared co-authors 8
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 16
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 9
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 47
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 17
Career Start Year 1995
Number of shared co-authors 9
Karolinska Institute
Career Start Year 1995
Number of shared co-authors 25
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 0
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 35
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 42
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 8
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 10
Queen's University
Career Start Year 1982
Number of shared co-authors 18
University of Toronto
Career Start Year 1980
Number of shared co-authors 19

Collaborators

University of Bern
Co-authored papers 36
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 32
New York-Presbyterian Hospital
Co-authored papers 30
Institute for Computational Biomedicine
Co-authored papers 26
Dana-Farber Cancer Institute
Co-authored papers 25
Meyer Cancer Center
Co-authored papers 23
Weill Cornell Medical College
Co-authored papers 19
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 17
Co-authored papers 15
Sandra and Edward Meyer Cancer Center
Co-authored papers 15
University of Trento
Co-authored papers 13
Weill Medical College of Cornell University
Co-authored papers 11
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 10
New York University Langone Health
Co-authored papers 9
Meyer Cancer Center
Co-authored papers 9
Sandra and Edward Meyer Cancer Center
Co-authored papers 9
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 8
Weill Cornell Medical Center
Co-authored papers 8
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 8
Case Western Reserve University
Co-authored papers 8
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 8
Meyer Cancer Center
Co-authored papers 7
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 7
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 7
Weill Cornell Medical College
Co-authored papers 7
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 7
Co-authored papers 7
University of Trento
Co-authored papers 6
New York Presbyterian Hospital-Weill Cornell
Co-authored papers 6
Sandra and Edward Meyer Cancer Center
Co-authored papers 6